Nicolae Testemițanu State University of Medicine and Pharmacy, Kishinev, Republic of Moldova
Corresponding author (vasile.sofronie[at]usmf.md)
The article contains epidemiological analysis of the incidence of chickenpox in the Republic of Moldova from 1985 to
2017. It is a longitudinal descriptive retrospective study. The results of the study showed that long-term incidence of chicken
pox from 2003 to 2016 had a pronounced upward trend in the Republic of Moldova. 60.19% of the respondents had
chickenpox in light form, and 39.18% of patients had chickenpox of medium severity. 44.17% of hospitalized patients had
chickenpox of medium severity, 25.77% of patients had a moderately severe chickenpox in association with other diseases,
9.20%, and 20.86% of patients had severe chickenpox in association with other diseases.
The average cost per patient for outpatient chickenpox treatment is $ 51.1. The average cost of treating one patient
hospitalized with chickenpox is $ 150.15. The average cost of treating one patient with chickenpox is $ 100.63.
The expenses connected with a lethal case comprise $ 167407.74. The costs associated with the purchase of Varivax
mono-vaccine comprise $ 743997.49 which is 1.64 times lower than the annual costs associated with the incidence of
chickenpox in the Republic of Moldova, which is $ 1222407.15. As for the costs associated with the acquisition of the
ProQuad combination vaccine, which is $474476.68, they are 2.58 times less than the annual losses associated with the
incidence of chickenpox.
The highest costs/losses per capita as a result of the incidence of chickenpox are recorded in Bălți – $ 2.5, and the
costs/expenses per capita for vaccinating children from 1 year of age in Bălți are 13.43 times less and comprise $ 0.19.
Keywords: chicken pox, retrospective study, morbidity, socio-economic impact, cost of vaccination.
Citește articolul integral - INFLUENCE ON HEALTH AND SOCIO-ECONOMIC EFFECTS OF DISEASE INCIDENCE OF CHICKENPOX IN THE REPUBLIC OF MOLDOVA